NOTE 20.

REVENUES BY PRODUCT CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS

Revenue Information

The following is a summary of our revenues by product category and represents our results from continuing operations (in thousands):

	Year Ended March 31,
Revenues by Product Category	2016		2015		2014
Instruments(1)	$	43,042	$	48,649	$	37,539
Consumables(2)		165,025		144,446		117,533
Other products(3)		10,760		9,348		6,809
Product sales, net		218,827		202,443		161,881
Development and licensing revenue		74		150		150
Total revenues	$	218,901	$	202,593	$	162,031

(1)	Instruments include chemistry analyzers, hematology instruments, VSpro specialty analyzers and i‑STAT analyzers.

(2)	Consumables include reagent discs, hematology reagent kits, VSpro specialty cartridges, i‑STAT cartridges and rapid tests.

(3)	Other products include products using the Orbos process and extended maintenance agreements.

The following is a summary of our revenues by geographic region based on customer location and represents our results from continuing operations (in thousands):

	Year Ended March 31,
Revenues by Geographic Region	2016		2015		2014
North America	$	175,019	$	163,308	$	126,768
Europe		31,262		30,422		27,161
Asia Pacific and rest of the world		12,620		8,863		8,102
Total revenues	$	218,901	$	202,593	$	162,031

Significant Concentrations

During fiscal 2016, three distributors in the United States, MWI Veterinary Supply, Inc., Patterson Companies, Inc. and Abbott Point of Care, Inc, accounted for 20%, 11% and 10%, respectively, and one distributor in both the United States and Europe, Henry Schein, Inc., accounted for 13% of our total worldwide revenues. During fiscal 2015, two distributors in the United States, MWI Veterinary Supply, Inc., and Abbott Point of Care, Inc. accounted for 19% and 11%, respectively, of our total worldwide revenues. During fiscal 2014, two distributors in the United States, MWI Veterinary Supply, Inc., and Abbott Point of Care, Inc. accounted for 19% and 10%, respectively, of our total worldwide revenues. Starting in the second quarter of fiscal 2016, our revenues from Patterson Companies, Inc. include both Patterson’s veterinary business and Animal Health International, Inc., as a result of Patterson’s acquisition of Animal Health International, Inc. Starting in fiscal 2016, our revenues from Henry Schein, Inc., include both Henry Schein, Inc. and scil animal care company GmbH, as a result of Henry Schein Inc.’s acquisition of scil animal care company GmbH in Europe.

Substantially all of our long-lived assets are located in the United States.